Confidential Materials omitted and filed with the Securities and Exchange Commission. Asterisks denote omissions.Exclusive Commercial Licence of Technology • November 7th, 2008 • Emergent BioSolutions Inc. • Pharmaceutical preparations
The licences in clauses 2.1.1, 2.1.2 and 2.1.3 are co-exclusive with the Company and the licences in clauses 2.1.4, 2.1.5 and 2.1.6 are, subject to clauses 2.9 and 2.11, exclusive.
